Authors: EVANS RW SHATEN BJ DAY BW KULLER LH

Citation: Rw. Evans et al., PROSPECTIVE ASSOCIATION BETWEEN LIPID-SOLUBLE ANTIOXIDANTS AND CORONARY HEART-DISEASE IN MEN - THE MULTIPLE RISK FACTOR INTERVENTION TRIAL, American journal of epidemiology, 147(2), 1998, pp. 180-186

Authors: EVANS RW SHATEN BJ HEMPEL JD CUTLER JA KULLER LH

Citation: Rw. Evans et al., HOMOCYST(E)INE AND RISK OF CARDIOVASCULAR-DISEASE IN THE MULTIPLE RISK FACTOR INTERVENTION TRIAL, Arteriosclerosis, thrombosis, and vascular biology, 17(10), 1997, pp. 1947-1953

Authors: SHATEN BJ KULLER LH KJELSBERG MO STAMLER J OCKENE JK CUTLER JA COHEN JD

Citation: Bj. Shaten et al., LUNG-CANCER MORTALITY AFTER 16 YEARS IN MRFIT PARTICIPANTS IN INTERVENTION AND USUAL CARE GROUPS, Annals of epidemiology, 7(2), 1997, pp. 125-136

Authors: ZIMMET PZ SHATEN BJ KULLER LH ROWLEY MJ KNOWLES WJ MACKAY IR

Citation: Pz. Zimmet et al., ANTIBODIES TO GLUTAMIC-ACID DECARBOXYLASE AND DIABETES-MELLITUS IN THE MULTIPLE RISK FACTOR INTERVENTION TRIAL, American journal of epidemiology, 140(8), 1994, pp. 683-690

Authors: SHATEN BJ SMITH GD KULLER LH NEATON JD

Citation: Bj. Shaten et al., RISK-FACTORS FOR THE DEVELOPMENT OF TYPE-II DIABETES AMONG MEN ENROLLED IN THE USUAL CARE GROUP OF THE MULTIPLE RISK FACTOR INTERVENTION TRIAL, Diabetes care, 16(10), 1993, pp. 1331-1339